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INTRODUCTION
Gallstone disease (GD) remains an important public health
problem, due to its extraordinary frequency (1). Despite its
common occurrence and profound impact, the pathogenesis
of gallstones remains incompletely understood. The report-
ed risk factors are obesity, female gender, childbearing, and
family history. New risk factors continue to be identified
(2). One of the most prominent risk factors in this regard is
insulin resistance. Many studies have implicated diabetes as
a risk factor of GD (3-6), but not all population-based epi-
demiological studies have come to this conclusion (7, 8),
and the strength of this association varied markedly across
studies. The explanations of the inconsistent findings are
due to limitations in design or statistical power, and also
that the insulin resistance that characterized most individu-
als who develop non-insulin-dependent diabetes mellitus
may be the primary factor involved in GD formation. A role
for insulin in GD has been identified by population-based
studies in univariate (9-11), but not multivariate analyses (9-
11). Few reports have thus far evaluated the association bet-
ween gallstones and insulin resistance in non-diabetic and
non-obese subjects (12). Therefore, it remains unclear as to
whether insulin resistance alone or in the presence of well-
known risk factors, including diabetes or obesity, is associat-
ed with gallstones.
Obesity is currently the best established predictor of GD;
this is significantly more consistent in women than in men.
Women have been shown to run a greater risk of GD than
men in the majority of studies. This pattern predominates
when subjects are younger, and the difference between sex
narrows with increasing age, particularly following meno-
pause. Female sex hormone is regarded as the reason for gen-
der differences (13). Obese men generally secrete more bile
acids and phospholipids into bile than do obese women; con-
sequently, the bile of obese men is less lithogenic, and they
tend to harbor fewer gallstones. In a few studies of men, obe-
sity per se was a weaker risk (14). Rather, gallstone disease is
more closely related with abdominal obesity, diabetes melli-
tus, and insulin resistance in white, black, and Hispanic pop-
ulations (4, 9, 15). However, from the representative data,
Ruhl et al., determined that both hyperinsulinemia and dia-
betes are independent risk factors in women, and that only
diabetes appears to be a risk factor in men. The principal
reason for the lack of an association may be the relatively low
prevalence of gallstones in men (3). The risk of gallstones in
men needs to be evaluated more thoroughly in a large pop-
ulation.
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Insulin Resistance is Associated with Gallstones Even in Non-obese,
Non-diabetic Korean Men
It remains unclear as to whether insulin resistance alone or in the presence of well-
known risk factors, such as diabetes or obesity, is associated with gallstones in men.
The aim of this study was to determine whether insulin resistance is associated
independently with gallstone disease in non-diabetic men, regardless of obesity.
Study subjects were 19,503 Korean men, aged 30-69 yr, with fasting blood glucose
level <126 mg/dL and without a documented history of diabetes. Gallbladder status
was assessed via abdominal ultrasonography after overnight fast. Body mass index
and waist circumference were measured. Insulin resistance was estimated by the
Homeostasis Model Assessment of insulin resistance (HOMA-IR). The prevalence
of obesity, abdominal obesity, and metabolic syndrome in the subjects with gall-
stones were higher than in those without. The prevalence of elevated HOMA (>75
percentile) in subjects with gallstones was significantly higher than in those with-
out, and this association remained even after the obesity stratification was applied.
In multiple logistic regression analyses, only age and HOMA proved to be inde-
pendent predictors of gallstones. Insulin resistance was positively associated with
gallstones in non-diabetic Korean men, and this occurred regardless of obesity.
Gallstones appear to be a marker for insulin resistance, even in non-diabetic, non-
obese men.
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The association between cholesterol gallstones and metabol-
ic syndrome or insulin resistance syndrome has been the sub-
ject of many recent reports (16). Although the Asian popu-
lation has a particular metabolic profile that differentiates
them from Western populations (17), there is currently only
minimal data regarding the relationship among GD and
insulin resistance syndrome in apparently healthy Asian men.
Therefore, the present cross-sectional study of non-diabet-
ic Korean men was conducted to determine whether insulin
resistance was associated with GD, regardless of obesity.
As the studies about risk factor of gallstone have been
conducted principally among symptomatic GD or cholecys-
tectomy patients, we focused in this study on nondiabetic
Korean men with gallstones prior to becoming symptomat-




The study population was composed of Korean male work-
ers at one of the largest semiconductor manufacturing com-
panies in Korea, as well as its 13 affiliates (18). All of the
workers were required to participate in either annual or bien-
nial health examinations, in accordance with the Industrial
Safety and Health Law in Korea. This cross-sectional study
included 19,503 of 21,572 Korean men, aged 30-69 yr, who
underwent medical screening at the Kangbuk Samsung Hos-
pital, Sungkyunkwan University School of Medicine, bet-
ween January 1 and October 10, 2005. Our study popula-
tion was comprised principally of asymptomatic subjects
who were referred to the check-up unit by their companies
as an annual requirement, and not for symptomatic disease.
In total, 1,792 men were excluded from this study on the
basis of the following exclusion criteria that might influence
insulin resistance and GD: 266 had histories of a chronic
medical illness or major surgery (stomach, small intestine,
and colon); 604 reported currently using antihypertensive,
antidiabetic, or blood lipid-lowering agents; 824 had fast-
ing blood glucose levels ≥126 mg/dL; 200 had a history of
cholecystectomy ; 43 had a US finding of sequelae of Clonorchis
sinensis infection; 34 had a US finding of other gallbladder
diseases such as gallbladder polyps, sludge, equivocal lesions,
or wall thickening. The Institutional Review Board at Kang-
buk Samsung Hospital approved this study.
Measurements and definitions
The health examinations included a medical history, a
physical examination, a questionnaire concerning health-
related behavior, anthropometric measurements, and bio-
chemical measurements. The medical history and a medica-
tion history of prescription drug use were evaluated by the
examining physicians. All of the participants were instruct-
ed to respond to a questionnaire regarding health-related
behavior. Questions regarding alcohol intake included the
frequency of alcohol consumption on a weekly basis, and
the usual amount consumed on a daily basis. Individuals
who reported smoking were identified as current smokers.
In addition, the participants were questioned regarding their
weekly frequency of physical activity, including jogging,
bicycling, and swimming that lasted long enough to gener-
ate perspiration. The blood specimens were sampled from
the antecubital vein after more than 12 hr of fasting. The
serum levels of fasting glucose, total cholesterol, triglyceride
(TG), low-density lipoprotein-cholesterol (LDL-C), and high-
density lipoprotein-cholesterol (HDL-C) were measured using
Bayer Reagent Packs on an automated chemistry analyzer
(ADVIA 1650TM Autoanalyzer, Bayer HealthCare Ltd., Tar-
rytown, NY, U.S.A.). The measurements utilized were as
follows: hexokinase method for glucose, enzymatic colori-
metric assay for LDL-C, HDL-C, total cholesterol, TG, and
immunoradiometric assay for insulin (Biosource, Nivelles,
Belgium). Insulin resistance was evaluated using the Home-
ostasis Model Assessment of Insulin Resistance (HOMA-IR):
fasting blood insulin (μ U/mL)×fasting blood glucose (mM/
L)/22.5. The Korean Association of Quality Assurance for
Clinical Laboratories assessed the quality control of the lab-
oratory, both internally and externally, on a regular basis. 
Trained nurses obtained sitting blood pressure levels using
a standard mercury sphygmomanometer. The first and fifth
Korotkoff sounds were utilized to estimate the systolic blood
pressure (SBP) and the diastolic blood pressure (DBP). Height
and weight were determined after an overnight fast with
the subjects wearing a lightweight hospital gown and no
shoes. The body mass index (BMI) was calculated as the
patient’s weight (kg) divided by the square of the patient’s
height (m). Waist circumference (WC) was evaluated by
two trained personnel, to the nearest 0.1 cm at the midpoint
between the bottom of the rib cage and the top of the iliac
crest with the participants standing, their weight distribut-
ed equally on both feet, their arms at their sides, and their
heads facing straight forward.
The ATP III proposed the following 5 abnormalities for
the definition of metabolic syndrome (19): 1) abdominal
obesity; 2) high fasting glucose ≥110 mg/dL; 3) hyper-
triglyceridemia: TG ≥150 mg/dL; 4) low HDL-C: HDL-C
<40 mg/dL; and 5) high blood pressure: ≥130/85 mmHg.
We substituted a Waist >90 cm for the threshold of abdom-
inal obesity, on the basis of Asia-Pacific criteria (20). In addi-
tion, analyses were conducted using metabolic syndrome as
defined on the basis of the criteria established by the Interna-
tional Diabetes Federation (IDF) (21).
The diagnosis of GD was established on the basis of the
results of abdominal US using a 3.5-MHz transducer. US
was conducted by three experienced radiologists, who were646 Y. Chang, E. Sung, S. Ryu, et al.
unaware of the objectives of the study and blinded to labora-
tory values. Gallstones were defined by the presence of strong
intraluminal echoes that were gravity-dependent or that atten-
uated ultrasound transmission (acoustic shadowing).
Statistical analyses
All statistical analyses were conducted using the SPSS
(version 13.0) software package. The results were demon-
strated as the mean±S.D, or the absolute number (percent-
ages). Chi-square tests, Student’s t-tests, or analysis of covari-
ance (ANCOVA) for adjusting for age, were employed in
order to determine the differences between 2 proportions or
means. Logarithm-transformed values of non-normal distri-
bution variables were utilized for comparisons between 2
groups. In order to control the effects of other gallstone-asso-
ciated covariates, we computed the adjusted gallstone preva-
lence estimates via binary logistic regression analyses. In order
to clarify the relationship between gallstone and insulin resis-
tance, regardless of obesity, analyses were conducted after
the subjects were stratified by obesity. Finally, multivariate
logistic regression analyses, using a backward procedure on
the basis of the likelihood ratios, were conducted in order to
determine the independent risk factors for gallstones in non-
diabetic subjects, and then in euglycemic subjects. The cri-
teria for variable removal and entry were established at 0.10
and 0.05, respectively. Hosmer and Lemeshow statistics were
utilized in order to assess the fit of the logistic regression
models. Both final models passed the goodness-of-fit test.
The odds ratio (OR) with 95% confidence intervals (95%CI)
was estimated. p values of <0.05 were considered to be sig-
nificant.
RESULTS
Of the 19,503 subjects, 440 (2.3%) had gallstones. The
subjects with gallstones were significantly older and evidenc-
ed higher measurements for BMI, waist circumference, sys-
tolic blood pressure, insulin, and HOMA than were observed
in the subjects without gallstones (Table 1). As (increasing)
age was identified as a potential confounder and we noted a
trend toward a greater proportion in the GD group, we con-
ducted age-adjusted ANCOVA (Table 1). Those whose alco-
hol intake was moderate had a lower prevalence of gallstones
compared to those whose alcohol intake was low or high.
Those who had participated in exercise more than 3 times








Age (yr) 42.5±8.1 42.4±8.1 45.7±9.2 <0.001
Smoking status 0.063
Never-smoked 5,683 (29.1) 5,553 (29.1) 130 (29.5)
<20 pack-years 8,941 (45.8) 8,760 (46.0) 181 (41.1)
≥20 pack years 4,879 (25.0) 4,750 (24.9) 129 (29.3)
Alcohol drinking  0.048
<10 g/day 5,327 (27.3) 5,187 (27.2) 140 (31.8)
10-40 g/day 10,917 (56.0) 106,95 (56.1) 222 (40.4)
≥40 g/day 3,259 (16.7) 3,181 (16.7) 78 (17.7)
Exercise, frequency/week 0.042
0 7,798 (40.0) 7,637 (40.1) 161 (36.6)
1-2 8,065 (41.4) 7,888 (41.4) 177 (40.2)
3- 3,640 (18.7) 3,538 (18.6) 102 (23.2)
Body mass index (kg/m
2) 24.4±2.7 24.4±2.7 24.7±2.8 0.006
Waist circumference (cm) 83.3±7.5 83.3±7.4 84.7±7.5 0.001
Total cholesterol (mg/dL) 195.9±32.3 195.8±32.3 196.5±34.3 0.782
LDL cholesterol (mg/dL) 114.7±27.2 114.7±27.2 115.8±28.4 0.588
Triglyceride (mg/dL)* 148.4±89.2 148.5±89.3 145.1±83.9 0.406
HDL cholesterol (mg/dL) 50.4±10.4 50.4±10.3 50.0±11.0 0.213
Systolic blood pressure (mmHg) 116.0±14.4 115.9±14.4 119.3±15.9 0.001
Diastolic blood pressure (mmHg) 80.0±9.6 80.0±9.6 81.4±10.1 0.062
Glucose (mg/dL) 96.8±8.8 96.8±8.8 98.3±9.7 0.067
Insulin* 8.8±3.6 8.8±3.6 9.3±4.1 0.001
HOMA index* 2.1±0.9 2.1±0.9 2.3±1.1 <0.001
Table 1. Characteristics of subjects based on gallstones
Data are mean±standard deviation (SD) or frequency (%). T-test for age; chi-square test for smoking, drinking, and exercise habits; age-adjusted
ANCOVA for all other variables; *logarithm transformed values were used for comparison. 
LDL, low-density lipoprotein; HDL, high-density lipoprotein; HOMA, Homeostasis Model Assessment Index. Insulin Resistance and Gallstones  647
frequent exercise. After subgroup analyses for exercise, fre-
quent exercisers were older, and likely to have higher BMI:
after controlling for age and BMI, there was no significant
association between the prevalence and exercise frequency
(data not shown). However, due to the possibility that habitual
smoking, drinking, and exercise were all potential confounders,
we adjusted the prevalence ratios for these factors in multi-
variate models (Table 2-4). 
In our age-adjusted logistic regression analyses, a higher
prevalence was observed with obesity, abdominal obesity,
and metabolic syndrome as defined by IDF (Table 2). After
considering hyperglycemia as fasting glucose ≥100 mg/dL
(8), the age-adjusted odds ratio of metabolic syndrome (defin-
ed by ATPIII) for gallstones was 1.40 (95% CI, 1.14-1.71)
(not shown in Table 2). None of the other components, with
the exception of abdominal obesity, was associated signifi-
cantly with the risk of GD. Two obesity indices (BMI and
WC) were moderately correlated with the log-transformed
HOMA values (age-adjusted r=0.466 for BMI; and age-
adjusted r=0.473 for WC).
In our age-adjusted analysis, higher HOMA indices were











Body mass index ≥25 (kg/m
2)  191 (2.5) 1.21 1.00-1.47 (0.050) 1.22 1.00-1.47 (0.047)
Waist circumference ≥90 (cm) 102 (2.9) 1.27 1.02-1.60 (0.036) 1.29 1.03-1.61 (0.030)
Glucose ≥100 (mg/dL) 179 (2.7) 1.16 0.96-1.42 (0.129) 1.17 0.96-1.43 (0.112)
Glucose ≥110 (mg/dL) 54 (3.3) 1.28 0.96-1.72 (0.099) 1.29 0.96-1.73 (0.090)
SBP ≥130 or DBP ≥85 (mmHg) 180 (2.7) 1.20 0.99-1.46 (0.069) 1.21 0.99-1.47 (0.058)
HDL cholesterol <40 (mg/dL) 61 (2.5) 1.15 0.87-1.51 (0.323) 1.15 0.87-1.51 (0.335)
Triglyceride ≥150 (mg/dL) 167 (2.4) 1.02 0.84-1.24 (0.852) 1.04 0.85-1.27 (0.698)
Metabolic syndrome (ATPIII)
� 65 (2.9) 1.24 0.95-1.62 (0.116) 1.26 0.96-1.65 (0.096)
Metabolic syndrome (IDF) 151 (3.1) 1.45 1.12-1.89 (0.006) 1.47 1.13-1.92 (0.004)
Table 2. Prevalence of gallstone disease based on the components of metabolic syndrome (n=19,503)
Data are expressed as frequency (%) and odds ratios at 95% confidence Interval (p value). *Multivariate-adjusted odds ratios were for age, smok-
ing habit, exercise habit, and alcohol drinking habit; 
� Criteria of abdominal obesity were defined as waist circumference >0.9 m (based on the Asia-
Pacific criteria), and the other criteria were defined based on ATP III (the Third Report of the National Cholesterol Education Program Adult Treatment
Panel). 












Body mass index <25 (kg/m
2) 1.01 1.00-1.02 (0.186) 1.01 1.00-1.02 (0.223)
Body mass index ≥25 (kg/m
2) 1.01 0.99-1.02 (0.366) 1.01 0.99-1.03 (0.262)
HOMA index 0.482
Body mass index <25 (kg/m
2) 1.16 0.98-1.36 (0.081) 1.16 0.98-1.36 (0.078)
Body mass index ≥25 (kg/m
2) 1.18 1.06-1.31 (0.003) 1.18 1.06-1.31 (0.003)
HOMA 75 percentile 0.577
Body mass index <25 (kg/m
2) 1.37 1.04-1.80 (0.024) 1.38 1.05-1.82 (0.021)
Body mass index ≥25 (kg/m
2) 1.52 1.12-2.07 (0.008) 1.53 1.12-2.09 (0.007)
Table 3. Prevalence ratios for gallstones based on insulin resistance stratified by obesity (n=19,503)
Data are expressed as odds ratios at 95% Confidence Interval [CI] (p value). *Multivariate-adjusted Odds Ratios were adjusted for age, cigarette
smoking, alcohol consumption, and exercise habit. 
HOMA, Homeostasis Model Assessment Index; HOMA 75 percentile of subjects <25 (kg/m
2): 2.22-10.50 units; HOMA 75 percentile of subjects with
≥25 (kg/m
2): 3.08-18.59 units.
Data are expressed as odds ratios at 95% Confidence Interval (p value).
*Multivariate models using the backward likelihood method were adjust-
ed for age, smoking habit, drinking habit, exercise habit, body mass
index (as a continuous variable; and then substituting abdominal obe-
sity as a categorical variable; substitution made no difference), waist
circumference, total cholesterol, glucose, and HOMA as independent
variables. 
HOMA, Homeostasis Model Assessment Index.
Multivariate-adjusted
odds ratio*
95% CI (p value)
Age (yr)  1.045 1.034-1.056 (<0.001)
Waist circumference (cm) 1.013 0.999-1.027 (0.073)
HOMA index 1.140 1.036-1.254 (0.007)
Table 4. Multivariate logistic regression analyses with gallstones
as the dependent variable (n=19,503)648 Y. Chang, E. Sung, S. Ryu, et al.
As compared with those in lower quartiles, increased gall-
stone prevalence was observed for those in the 4th quartile
of the HOMA, and this persisted even after the subjects were
stratified by obesity. 
Finally, our multiple logistic regression included age, smok-
ing habit, drinking habit, exercise habit, BMI (as a continu-
ous variable and then substituting abdominal obesity as a
categorical variable; substitution made no difference), waist
circumference, total cholesterol, glucose, and HOMA as inde-
pendent variables and gallstones as the dependent variable. In
multivariate models using the backward likelihood method,
only age and HOMA were associated significantly with gall-
stones (Table 4).
DISCUSSION
In the current study of non-diabetic Korean men, age and
the HOMA index were associated with gallstones. Even after
obesity stratification was applied, the positive association
between gallstones and insulin resistance, as defined by the
4th quartile of HOMA, remained. To the best of our knowl-
edge, this study is the first to demonstrate that the relation-
ship between insulin resistance and gallstone persisted in
non-obese subjects. 
Scragg et al. were among the first to evaluate the relation-
ship between plasma insulin levels and gallstone risk. In a
1984 hospital-based case control analysis, they determined
the fasting insulin means to be higher in gallstone cases of
both sexes, regardless of age and triglyceride levels (22). In a
small case-control study, fasting insulin was higher in the
gallstone group (23). However, in a large, population-based
survey, the prevalence of clinical gallbladder disease rose
with increasing insulinemia among nondiabetic women;
however, this relationship was no longer significant after
adjustment for potential confounders (10). In a population-
based biliary ultrasonographic survey, Heaton et al. deter-
mined that nondiabetic British men with the highest levels
of insulin had twice the risk of gallstones as those with low
levels, but the relationship proved insignificant after the sub-
jects were matched for waist-to-hip ratio (9). An ultrasono-
graphic survey from Mexico City found that the mean fast-
ing insulin levels in women with gallstones were higher than
those of the controls, although no such relationship was detect-
ed in men (11). Ruhl and Everhart have clarified the rela-
tionship of insulinemia to gallstones in the large scale, NH-
ANES III in women, but not in men. The Asian population
was not included in this study (3). 
Obesity is a well-established, major risk factor for the devel-
opment of gallstones, with the basis being an increased hep-
atic secretion of cholesterol. This risk is particularly high in
obese women than in obese men. 
In men, obesity per se was a weaker risk (14). Rather, GD is
more closely related with abdominal obesity, diabetes melli-
tus, and insulin resistance (4, 9, 15). In this study of Korean
men, obesity was not determined to be a significant predic-
tor for gallstones; rather, age and insulin resistance were asso-
ciated with gallstones. 
As has been documented in previous studies, other risk
factors, including the presence of metabolic syndrome as an
insulin resistance phenotype was associated with an increased
prevalence of gallstones (24). However, in these non-diabet-
ic men, among all of the characteristics of metabolic syn-
drome, waist circumference was the only factor that was sig-
nificantly associated with the risk of developing gallstones.
Several studies have indicated that abdominal adiposity or
waist circumference is associated with GD (4, 9, 14, 15).
Metabolic syndrome in accordance with IDF criteria predict-
ed gallstones better than did metabolic syndrome as defined
by NCEP criteria, because waist circumference was a better
predictor of gallstones than cholesterol or fasting glucose. 
Waist circumference was a better predictor for gallstones
than BMI in men in our study. Another study corroborated
that waist circumference predicted gallstones better than
did BMI in men (9, 15). Waist circumference is a better indi-
cator of total body fat than is BMI (25). In addition, waist
circumference, which is essentially an indicator of abdomi-
nal fat, proved to be rather predictive for metabolic compli-
cations (19). 
The pathogenesis of cholesterol GD is known to be mul-
tifactorial, with an interaction of genetic and environmental
factors resulting in bile supersaturation, gallbladder hypo-
motility, and the precipitation/nucleation of cholesterol mic-
rocrystals (26).
Insulin levels have been correlated with biliary cholesterol
saturation (27). Insulin has been shown previously to aug-
ment the activity of hydroxymethylglutaryl coenzyme A
reductase, the rate-limiting step in cholesterol synthesis (28).
The risk of GD attributable to insulin resistance may not be
solely explained by insulin. However, at least in part, it remains
simply a surrogate for other pathophysiological factors. 
This study had several limitations. First, abdominal adi-
posity was not evaluated by more accurate methods, includ-
ing computed tomography (CT), dual-energy radiography
absorptiometry (DEXA), and magnetic resonance imaging
(MRI), as these are costly and impractical for routine clini-
cal practice. They have, thus far, been used principally for
research purposes. Second, the definition of insulin resistance
in this study was predicated on only a single insulin mea-
surement. We estimated insulin resistance on the basis of
insulin levels and HOMA analyses, not on euglycemic insulin
clamp analyses, which are impossible to use for large popu-
lations. Third, we were unable to include dietary informa-
tion, which could be possible confounders for gallstones.
Forth, the exact types of gallstones were not determined.
Pigment stones proved to be more frequent in the Korean
population 30 to 40 yr ago, but the pattern changed rapidly
(29, 30). More than half of gallstones were cholesterol stonesInsulin Resistance and Gallstones  649
by 1990, and cholesterol stones are thought to represent a
common condition, especially in younger individuals. In
the present study, we tried to minimize by excluding sub-
jects with Clonorchis sinensis-related sequelae (parasites causing
infectious stones) on the basis of ultrasonic findings, and we
excluded subjects in postcholecystectomy states due to the
possibility of misclassification from other causes. At present,
it is unknown whether insulin resistance might be associated
with pigment stones. The heterogeneity of gallstones, if pre-
sent, would tend to reduce the strength of the association
between HOMA and gallstones. 
In conclusion, the findings of this study lead us to the
conclusion that even in an Asian, non-diabetic male popula-
tion, insulin resistance appears to be an independent predic-
tor of gallstones, regardless of obesity. Therefore, gallstones
appear to be a marker for insulin resistance, even in non-
diabetic, non-obese men. 
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